Alexa Fluor^® 647 Rat Anti-Mouse Ig, κ Light Chain Antibody (S-4252)

Immunoglobulin kappa (Igκ) light chains are one of the two types of polypeptide chains, alongside lambda chains, that constitute the antigen-binding fragment of antibodies in humans and many other mammals, playing a critical role in the adaptive immune system's ability to recognize diverse pathogens. Each antibody molecule typically comprises two identical heavy chains and two identical light chains, where the kappa light chain consists of a variable domain (Vκ) responsible for antigen specificity through hypervariable complementarity-determining regions (CDRs), and a constant domain (Cκ) that provides structural stability and facilitates proper folding and assembly with the heavy chain within the endoplasmic reticulum of B cells. In humans, the immunoglobulin light chain locus is located on chromosome 2, and during B cell development, V-J recombination generates immense diversity in the Vκ region, allowing the immune system to produce billions of unique antibodies; notably, each B cell expresses exclusively either kappa or lambda light chains, a phenomenon known as allelic exclusion, which ensures monospecificity, with kappa chains being more prevalent than lambda chains in human serum at an approximate ratio of 60:40. Clinically, the detection of free kappa light chains or an abnormal kappa-to-lambda ratio is a vital diagnostic marker for B-cell malignancies such as multiple myeloma and light chain amyloidosis, as clonal proliferation often results in the overproduction of a single type of light chain that can be measured in blood or urine to monitor disease progression and treatment response.